Comparison of three ELISA techniques for the evaluation of IgG seroprevalence against Bordetella pertussis in children vaccinated with three doses of DTPwc;Comparación de tres técnicas ELISA para evaluar la seroprevalencia de IgG frente a Bordetella pertussis en niños vacunados con tres dosis de DTPe

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 20, Issue 1, 2002, Pages 10-15

  Sanz, Juan Carlos ^a   Fernández, Marisa ^a   Sagües, María Jesús ^a   Ramírez, Rosa ^b   Castañeda, Rosario ^b   Barranco, Dolores ^c   De Ory, Fernando ^d  

^a Laboratorio Regional de Salud Publica   (Spain)

^b Instituto de Salud Pública   (Spain)

^c Servicio de Prevención y Salud Laboral   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Bordetella pertussis; Children; ELISA; Seroprevalence

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; IMMUNOGLOBULIN G;

ARTICLE; BORDETELLA PERTUSSIS; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNITY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NONHUMAN; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SEROPREVALENCE; VACCINATION;

EID: 0346489677     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0213-005x(02)72724-9     Document Type: Article

References (24)

1. Greco D, Salmaso S, Mastrantonio P, Giuliamo M, Tozzi AE, Anemona A, et al, and The Progetto Pertosse Working Group. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 1996;334:341-7.
2. Gustafsson L, Hallander HO, Olin P, Reinzenstein E, Storsaeter J. A controlled trial of two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 1996;334:349-55.
3. Cattaneo LA, Reed GW, Haase DH, Wills MJ, Edwards KM. The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years. J Infect Dis 1996;173:1256-9.
4. Giammanco A, Chiarini A, Stroffolini T, De Mattia D, Chiaramonte M, Moschen ME, et al. Seroepidemiology of pertussis in Italy. Rev Infect Dis 1991;13:1216-20.
5. Stroffolini T, Giammanco A, Chiarini A, Taormina S, Sarzana A, Mazza G, Maggio M, Chiaramonte M, Ngatchu T, Lantum D. Seroepidemiology of pertussis infection in an urban childhood population in Cameroon. Eur J Epidemiol 1991;7:64-7.
6. Reizenstein E, Hallander HO, Blackwelder WC, Kühn I, Ljungman M, Möllby R. Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model. J Immunol Methods 1995;183: 279-90.
7. Mink CM, O'Brien CH, Wassilak S, Deforest A, Meade B. Isotype and antigen specificity of pertussis agglutinins following whole-cell pertussis vaccination and infection with Bordetella pertussis. Infect Immun 1994;62: 1118-20.
8. Dirección General de Prevención y Promoción de la Salud. Consejería de Salud, Comunidad de Madrid. II Encuesta de Serovigilancia de la Comunidad de Madrid. Documentos Técnicos de Salud Pública 1995;29.
9. Müller FMC, Hoppe JE, Wirsing von König CH. Laboratory diagnosis of pertussis: state of the art in 1997. J Clin Microbiol 1997;35:2435-43.
10. Sapian-López LA, Valdespino JL, Salvatierra B, Tapia-Conyer R, Gutiérrez G, Macedo J, et al. Seroepidemiology of whooping cough in México. Salud Publica Mex 1992;34:177-85.
11. Takayama N, Watanabe H, Fujita I, Minamitani M. Seroepidemiology of pertussis in the Japanese population. Med Microbiol Immunol 1989;178:1-8.
12. Arav-Boger R, Ashkenazi S, Gdalevich M, Cohen D, Danon YL. Seroprevalence of pertussis antibodies among adolescents in Israel. Isr Med Assoc J 2000;2:174-7.
13. Chiu TF, Lee CY, Lee PI, Lu CY, Lin HC, Huang LM. Pertussis seroepidemiology in Taipei. J Formos Med Assoc 2000;99:224-8.
14. He Q, Mertsola J, Himanen JP, Ruuskanen O, Viljanen MK. Evaluation of pooled and individual components of Bordetella pertussis as antigens in an enzyme immunoassay for diagnosis of pertussis. Eur J Clin Microbiol Infect Dis 1993;12:690-5.
15. Ortega P, Gil A, Astasio P, Domínguez V, de Juanes JR, Arrazola P, et al. Prevalencia de anticuerpos frente a tétanos, difteria y Bordetella pertussis en profesionales sanitarios. Enferm Infecc Microbiol Clin 1999;17:135-7.
16. Astasio P, Gil A, Ortega P, Martínez D, Domínguez V, Gonzalez A. Seroprevalencia de anticuerpos frente a tétanos, difteria y Bordetella pertussis en una población de adultos jóvenes. Vacunas 2000;1:7-9.
17. rd ed.). Washington, DC: American Society for Microbiology, 1986; p. 388-94.
18. Wirsing von König CH, Schmitt HJ. Epidemiologic aspects and diagnostic criteria for protective efficacy field trial of a pertussis vaccine. J Infect Dis 1996;174(3Suppl):281S-6S.
19. García-Corbeira P, Dal Re R, Aguilar L, García de Lomas J. Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross-sectional study. Vaccine 2000;18:2173-6.
20. Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study. BMJ 1988;296:612-4.
21. Centro Nacional de Epidemiología. Instituto de Salud Carlos III. Ministerio de Sanidad y Consumo. Cobertura vacunal 1996. Bol Epidemiol Sem 1997; 5:37-8.
22. Centro Nacional de Epidemiología. Instituto de Salud Carlos III. Ministerio de Sanidad y Consumo. Cobertura vacunal 1997. Bol Epidemiol Sem 1998; 6:197-208.
23. Isacson J, Trollfors B, Hedvall G, Taranger J, Zackrisson G. Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis. Scand J Infect Dis 1995;27:273-7.
24. Grimpel E, Begué P, Anjak I, Njamkepo E, Francois P, Guiso N. Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France. Clin Diag Lab Immunol 1996;3:93-7.